A detailed history of Pettyjohn, Wood & White, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pettyjohn, Wood & White, Inc holds 6,792 shares of BMY stock, worth $395,498. This represents 0.06% of its overall portfolio holdings.

Number of Shares
6,792
Previous 6,792 -0.0%
Holding current value
$395,498
Previous $282,000 24.47%
% of portfolio
0.06%
Previous 0.05%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $8,050 - $10,598
-200 Reduced 2.86%
6,792 $282,000
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $21,234 - $25,338
-438 Reduced 5.9%
6,992 $358,000
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $7,120 - $7,961
123 Added 1.68%
7,430 $431,000
Q2 2023

Aug 10, 2023

BUY
$63.71 - $70.74 $15,927 - $17,685
250 Added 3.54%
7,307 $467,000
Q1 2023

Apr 25, 2023

SELL
$65.71 - $74.53 $6,570 - $7,453
-100 Reduced 1.4%
7,057 $489,000
Q2 2022

Aug 08, 2022

BUY
$72.62 - $79.98 $18,009 - $19,835
248 Added 3.59%
7,157 $551,000
Q3 2021

Nov 08, 2021

SELL
$59.17 - $69.31 $5,917 - $6,931
-100 Reduced 1.43%
6,909 $409,000
Q2 2021

Aug 03, 2021

SELL
$61.91 - $67.42 $15,477 - $16,855
-250 Reduced 3.44%
7,009 $468,000
Q1 2021

May 10, 2021

BUY
$59.34 - $66.74 $474 - $533
8 Added 0.11%
7,259 $458,000
Q4 2020

Feb 04, 2021

SELL
$57.74 - $65.43 $2,887 - $3,271
-50 Reduced 0.68%
7,251 $450,000
Q3 2020

Oct 26, 2020

SELL
$57.43 - $63.64 $4,766 - $5,282
-83 Reduced 1.12%
7,301 $440,000
Q2 2020

Aug 04, 2020

SELL
$54.82 - $64.09 $13,705 - $16,022
-250 Reduced 3.27%
7,384 $434,000
Q1 2020

Apr 20, 2020

BUY
$46.4 - $67.43 $4,732 - $6,877
102 Added 1.35%
7,634 $426,000
Q4 2019

Feb 11, 2020

SELL
$49.21 - $64.19 $6,249 - $8,152
-127 Reduced 1.66%
7,532 $483,000
Q2 2019

Aug 02, 2019

BUY
$44.62 - $49.34 $107,355 - $118,712
2,406 Added 45.8%
7,659 $347,000
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $68,435 - $77,190
-1,240 Reduced 19.1%
5,253 $326,000
Q2 2018

Aug 13, 2018

SELL
$50.53 - $62.98 $6,669 - $8,313
-132 Reduced 1.99%
6,493 $359,000
Q1 2018

May 11, 2018

BUY
$59.92 - $68.98 $5,992 - $6,898
100 Added 1.53%
6,625 $419,000
Q4 2017

Feb 13, 2018

SELL
$59.94 - $65.35 $35,964 - $39,210
-600 Reduced 8.42%
6,525 $400,000
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $393,513 - $454,147
7,125
7,125 $454,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Pettyjohn, Wood & White, Inc Portfolio

Follow Pettyjohn, Wood & White, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pettyjohn, Wood & White, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pettyjohn, Wood & White, Inc with notifications on news.